Meritage Portfolio Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$299K Sell
6,450
-99,496
-94% -$4.61M 0.02% 286
2025
Q1
$6.46M Sell
105,946
-480
-0.5% -$29.3K 0.43% 68
2024
Q4
$6.02M Sell
106,426
-1,838
-2% -$104K 0.37% 68
2024
Q3
$5.6M Buy
108,264
+102,782
+1,875% +$5.32M 0.34% 89
2024
Q2
$228K Sell
5,482
-46
-0.8% -$1.91K 0.01% 313
2024
Q1
$300K Sell
5,528
-9,766
-64% -$530K 0.02% 297
2023
Q4
$785K Sell
15,294
-53,868
-78% -$2.76M 0.05% 212
2023
Q3
$4.01M Sell
69,162
-655
-0.9% -$38K 0.3% 112
2023
Q2
$4.47M Buy
69,817
+2,126
+3% +$136K 0.32% 109
2023
Q1
$4.69M Buy
67,691
+27,776
+70% +$1.93M 0.35% 99
2022
Q4
$2.87M Buy
39,915
+1,288
+3% +$92.7K 0.22% 146
2022
Q3
$2.75M Buy
38,627
+1,916
+5% +$136K 0.23% 128
2022
Q2
$2.83M Sell
36,711
-43,371
-54% -$3.34M 0.22% 134
2022
Q1
$5.85M Buy
80,082
+1,022
+1% +$74.6K 0.36% 79
2021
Q4
$4.93M Buy
79,060
+24,009
+44% +$1.5M 0.28% 105
2021
Q3
$3.26M Sell
55,051
-136
-0.2% -$8.05K 0.2% 127
2021
Q2
$3.69M Buy
55,187
+274
+0.5% +$18.3K 0.22% 133
2021
Q1
$3.47M Buy
54,913
+11,619
+27% +$734K 0.23% 131
2020
Q4
$2.69M Buy
43,294
+1,971
+5% +$122K 0.2% 145
2020
Q3
$2.49M Sell
41,323
-3,067
-7% -$185K 0.22% 121
2020
Q2
$2.61M Sell
44,390
-4,225
-9% -$248K 0.25% 119
2020
Q1
$2.71M Sell
48,615
-29,044
-37% -$1.62M 0.37% 80
2019
Q4
$4.99M Sell
77,659
-28,144
-27% -$1.81M 0.44% 63
2019
Q3
$5.37M Buy
105,803
+2,107
+2% +$107K 0.51% 53
2019
Q2
$4.7M Buy
103,696
+42,058
+68% +$1.91M 0.48% 71
2019
Q1
$2.94M Buy
+61,638
New +$2.94M 0.3% 130
2018
Q4
Sell
-115,291
Closed -$7.16M 175
2018
Q3
$7.16M Sell
115,291
-1,603
-1% -$99.5K 0.66% 37
2018
Q2
$6.47M Buy
116,894
+22,006
+23% +$1.22M 0.63% 44
2018
Q1
$6M Sell
94,888
-405
-0.4% -$25.6K 0.58% 61
2017
Q4
$5.84M Buy
+95,293
New +$5.84M 0.56% 74